- Home
- CIGI vs CORT Comparison
CIGI vs CORT Comparison
Compare CIGI & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIGI
- CORT
- Stock Information
- Founded
- CIGI 1972
- CORT 1998
- Country
- CIGI Canada
- CORT United States
- Employees
- CIGI N/A
- CORT N/A
- Industry
- CIGI
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- CIGI
- CORT Health Care
- Exchange
- CIGI Nasdaq
- CORT Nasdaq
- Market Cap
- CIGI 7.7B
- CORT 7.6B
- IPO Year
- CIGI N/A
- CORT N/A
- Fundamental
- Price
- CIGI $159.53
- CORT $73.47
- Analyst Decision
- CIGI Buy
- CORT Strong Buy
- Analyst Count
- CIGI 7
- CORT 4
- Target Price
- CIGI $175.00
- CORT $139.00
- AVG Volume (30 Days)
- CIGI 113.8K
- CORT 946.3K
- Earning Date
- CIGI 11-04-2025
- CORT 11-04-2025
- Dividend Yield
- CIGI 0.19%
- CORT N/A
- EPS Growth
- CIGI N/A
- CORT N/A
- EPS
- CIGI 2.21
- CORT 1.11
- Revenue
- CIGI $5,169,495,000.00
- CORT $716,080,000.00
- Revenue This Year
- CIGI $16.18
- CORT $28.85
- Revenue Next Year
- CIGI $7.46
- CORT $34.98
- P/E Ratio
- CIGI $72.40
- CORT $65.92
- Revenue Growth
- CIGI 16.63
- CORT 25.71
- 52 Week Low
- CIGI $100.86
- CORT $42.01
- 52 Week High
- CIGI $171.51
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- CIGI 49.21
- CORT 42.85
- Support Level
- CIGI $153.53
- CORT $70.89
- Resistance Level
- CIGI $171.20
- CORT $74.77
- Average True Range (ATR)
- CIGI 3.13
- CORT 3.03
- MACD
- CIGI 0.35
- CORT -0.67
- Stochastic Oscillator
- CIGI 41.12
- CORT 36.84
About CIGI Colliers International Group Inc. Subordinate Voting Shares
Colliers International Group Inc provides commercial real estate professional services and investment management to corporate and institutional clients across different countries around the world. Its operating segments are; Real Estate Services, Engineering, Investment Management, and Corporate. Maximum revenue for the company is generated from its Real Estate Services segment, which offers services like transaction and debt finance services, outsourcing in property management, valuation and advisory, loan servicing, property sales brokerage, and lease brokerage services, among others. Geographically, the company generates maximum revenue from the United States and the rest from Canada, Australia, the United Kingdom, Poland, China, India, and other regions.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.